Intro of CIRM‘s press release on the “first of its kind center to accelerate stem cell development” that will be located in San Diego:

“How do you overcome obstacles slowing the progress of even the most promising stem cell therapies? Simple, you create a new, innovative center that has the skill, experience and expertise to help researchers move their work out of the lab and into clinical trials in people.

The governing Board of CIRM, the California Institute for Regenerative Medicine, today approved investing $15 million in a partnership with Quintiles Transnational Inc. to create a stem cell Accelerating Center. This unique institution will provide researchers with the support and management services they need to increase the likelihood their clinical trials will succeed.

CIRM projects run through the Accelerating Center will be given a discount on services. CIRM expects to receive a $22.5 million, or 50 percent, return on its $15 million investment.

“Many scientists are brilliant researchers but have little experience or expertise in navigating the regulatory process; this Accelerating Center means they don’t have to develop those skills, we provide them for them,” says C. Randal Mills, Ph.D., President and CEO of CIRM. “This partnership with Quintiles means that CIRM projects will not only be accelerated, but that CIRM will also realize a reasonable financial return on this investment.”

Full release

Additional coverage